Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
about
Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical RelevanceErythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice.N-3 polyunsaturated fatty acids increase hepatic fibroblast growth factor 21 sensitivity via a PPAR-γ-β-klotho pathway.Fasting-induced hormonal regulation of lysosomal function.Adult-onset obesity is triggered by impaired mitochondrial gene expression.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21.FGF21-induced by carbon monoxide mediates metabolic homeostasis via the PERK/ATF4 pathway.TCF4/β-catenin complex is directly upstream of FGF21 in mouse stomach cancer cells.DEPTOR Suppresses Lipogenesis and Ameliorates Hepatic Steatosis and Acute-on-Chronic Liver Injury in Alcoholic Liver Disease.Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis.SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress.Ileal Transposition Surgery Decreases Fat Mass and Improves Glucose Metabolism in Diabetic GK Rats: Possible Involvement of FGF21.Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms.Bile acid metabolism and signaling in liver disease and therapyChanges in Liver Gene Expression and Plasma Concentration of Rbp4, Fetuin-A, and Fgf21 in Sprague-Dawley Rats Subjected to Different Dietary Interventions and Bariatric Surgery
P2860
Q33882332-3A6DF200-81D0-46AD-94D1-2A426D6088D0Q36306157-FB411728-7DF9-4C12-ABC7-C02C09080294Q38858879-254028D1-19C2-4334-B28F-242EBA2DB6C9Q41070270-130FC4B1-4E09-4BD4-A61A-F2F9F943B9FAQ41434819-15371DFE-A42F-4501-AE73-DCB30319E25EQ41921861-2DAD9938-0284-4FB0-AB73-D8508BE38B91Q47610112-46D989EF-5826-4152-BBF3-DC11A312F8A1Q49359562-35F01579-0E69-40D1-AD23-42FA75659B52Q49420809-E07EB26F-D265-4645-82AD-92BABE7C75BBQ49850633-DB5CE1FF-F3AE-4D12-9AEA-F421F18BB15AQ50212100-3F7D3CBF-BE5D-41A2-9F1E-57E6A8A505F6Q51036933-622D3F97-93FB-4D2E-879B-995940A77A83Q51244068-8BF60AF1-B07D-44B5-92B0-F8F9F32B941EQ52385007-A9A2CB42-3930-414E-A588-B06512C219ACQ57128767-3A926C9C-73BD-467A-A062-5702327E946BQ58772800-76A5D4D6-940C-49CB-A08C-5D6731763808
P2860
Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Fibroblast growth factor 21 im ...... f rapamycin complex 1 in mice.
@en
type
label
Fibroblast growth factor 21 im ...... f rapamycin complex 1 in mice.
@en
prefLabel
Fibroblast growth factor 21 im ...... f rapamycin complex 1 in mice.
@en
P2093
P2860
P356
P1433
P1476
Fibroblast growth factor 21 im ...... f rapamycin complex 1 in mice.
@en
P2093
Aoyuan Cui
Feifan Guo
Feifei Zhang
Haoyang Jiang
Mengwei Zang
P2860
P304
P356
10.1002/HEP.28523
P407
P577
2016-02-29T00:00:00Z